Moser Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Moser Wealth Advisors's XBI Position: Q1 2025 in Review
Moser Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 1,452 shares — an estimated $131K sold.
Moser Wealth Advisors first reported a position in XBI in Q2 2021 and held it in 14 quarters. The position peaked at $166K in Q3 2024. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.
- Moser Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
- Moser Wealth Advisors sold 1,452 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $131K.
- Moser Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 14 quarters.
- Moser Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $166K in Q3 2024.
- 682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.
Based on Moser Wealth Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.